P M Ford
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
P M Ford has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
D. Bell
Clinical Immunology Outpatient Clinic, Kingston General Hospital, Kingston, Ontario, Canada
1 shared publicationJ. Austin
Community Health and Epidemiology, Queen's University, Kingston
1 shared publicationM Pearson
Department of Family Medicine, Queen's University, Kingston, Ontario
1 shared publicationM. Pearson
Family Medicine and
1 shared publicationP S Mistry
1 shared publicationP. Sankar‐Mistry
Public Health Laboratory, Kingston, and
1 shared publication
Latest Publications
- Open Access
- 1 February 2000
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 93 (2) , 113-119
HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary
In a voluntary anonymous HIV and hepatitis C serology screen in a Canadian male medium security federal penitentiary, 68% of 520 prisoners volunteered a blood sample and 99% of those giving a blood sample completed a risk behaviour questionnaire which was linked numerically to the blood sample. Compared to previous screenings for HIV (4 years earlier), and hepatitis C (3 years earlier) in the same institution, HIV seroprevalence had risen from 1% to 2% and hepatitis C seroprevalence from 28% to 33%. The overwhelming risk association for hepatitis C was with drug use outside prison, although there was a small group of men who had only ever injected drugs inside prison, over half of whom had been infected with hepatitis C. The proportion of prisoners who had injected drugs in prison rose from 12% in 1995 to 24% in 1998. The proportion of surveyed individuals sharing injection equipment at some time in prison was 19%, and while HIV rates in the prison are currently low, HIV prevalence amongst Canadian street i.v. drug users is rising rapidly, underlining the need for urgent preventative measures in prisons.
- 1 February 2000
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 93 (2) , 113-119
Open AccessHIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary
In a voluntary anonymous HIV and hepatitis C serology screen in a Canadian male medium security federal penitentiary, 68% of 520 prisoners volunteered a blood sample and 99% of those giving a blood sample completed a risk behaviour questionnaire which was linked numerically to the blood sample. Compared to previous screenings for HIV (4 years earlier), and hepatitis C (3 years earlier) in the same institution, HIV seroprevalence had risen from 1% to 2% and hepatitis C seroprevalence from 28% to 33%. The overwhelming risk association for hepatitis C was with drug use outside prison, although there was a small group of men who had only ever injected drugs inside prison, over half of whom had been infected with hepatitis C. The proportion of prisoners who had injected drugs in prison rose from 12% in 1995 to 24% in 1998. The proportion of surveyed individuals sharing injection equipment at some time in prison was 19%, and while HIV rates in the prison are currently low, HIV prevalence amongst Canadian street i.v. drug users is rising rapidly, underlining the need for urgent preventative measures in prisons.
- 30 July 1995
- Vol. 21 (14) , 134-6
Voluntary screening for hepatitis C in a Canadian federal penitentiary for men.
- 30 July 1995
- Vol. 21 (14) , 134-6
Voluntary screening for hepatitis C in a Canadian federal penitentiary for men.